Gene Synthesis Market Size to Cross USD 17.99 Bn by 2032

Published Date : 16 May 2024

The global gene synthesis market size surpassed USD 2.60 billion in 2023 and is estimated to cross around USD 17.99 billion by 2032, poised to grow at a CAGR of 23.97% from 2023 to 2032. The increasingly favorable government initiatives regarding synthetic biology are attributed to driving the growth of the gene synthesis market.

Gene Synthesis Market Size and Growth Rate From 2023 to 2032

Market Overview

The gene synthesis market is the artificial feature of DNA sequences, typically using automated DNA synthesis machines or chemical methods. It enables researchers to produce and design custom DNA molecules with specified sequences and allows the study of genetic engineering, protein expression, and gene function. Decided therapy in combination with chemotherapy and immunotherapy is expected to drive the market growth.

The increasing prevalence of various chronic diseases and genetic disorders is anticipated to enhance the market growth. In addition, increasing concerns about genetic disorders are considered to drive the adoption of the rate of subsequent treatment and gene synthesis, increasing emergence of various infectious diseases and growing government funding for research and development activities in the pharmaceutical industry is further anticipated to drive the growth of gene synthesis market during the forecast period.

Rising government and academic research institutes engaged in genetic and genomics engineering projects, which is fueling the market growth

Government and academic research institutes highly integrate gene synthesis services to complete fundamental science studies, genetic engineering, and genomics projects. Due to the growing capacity of the industry, more diverse end users are searching for gene synthesis solutions. Partnerships and collaboration activities are improving innovation offered for gene synthesis by contract research organizations, biotechnology companies, and academic institutions. These collaborative agreements are enhancing research and product development in various industries.

In addition, academic and government research organizations tailor these services for their genetic and genomics engineering projects. These are the major driving factors anticipated to enhance the growth of the gene synthesis market during the forecast period.

However, a lack of skilled professionals and data misuse may restrain the market's growth. The scarcity of industry professionals is one of the major factors hindering market growth. Misuse of gene synthesis in forensic research and other gene synthesis purposes may disturb the safety and security of data and may reduce gene synthesis’s market share.

In addition, factors such as technical limitations, tempting price reductions, fierce competition in the manufacturing process, and lack of knowledge of professionals can't improve and develop the gene synthesis process. These are the major hindering factors that may restrain the growth of the gene synthesis market.

Gene Synthesis Market Report Scope

Report Coverage Details
Market Revenue in 2023 USD 2.60 Billion
Projected Forecast Revenue by 2032 USD 17.99 Billion
Growth Rate from 2023 to 2032 CAGR of 23.97%
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Gene Synthesis Market Top Companies

  • GenScript Biotech Corporation
  • Molecular Assemblies, Inc
  • Integrated DNA Technologies, Inc
  • Eurofins Scientific
  • Quintara Biosciences
  • Eton Biosciences
  • Twist Biosciences
  • IBM GmbH
  • Thermo Fisher Scientific
  • BioCat GmbH
  • OriGene Technologies, Inc.
  • ProMab Biotechnologies, Inc.
  • Boster Biological Technology

Recent Development by Twist Bioscience Corporation

  • In November 2024, Twist Bioscience Corporation launched a new leading gene synthesis service, Twist Express Genes. This new gene synthesis service has to ship within five to seven business days. The Twist Bioscience company allows customers to succeed in providing higher-quality synthetic DNA with the use of a silicon platform.

Recent Development by Molecular Assemblies, Inc.

  • In May 2024, a leader in the field of enzymatic DNA synthesis and Molecular Assemblies, Inc., launched its Partnering Program to allow Molecular company Fully Enzymatic Synthesis advanced technology for on-site synthesis. Fully Enzymatic Synthesis enhances the production of accurate, pure, and long DNA to energy a new, rapidly developing generation of diagnostics and therapeutics.

Regional Insights

North America dominated the gene synthesis market in 2023. The increasing prevalence of chronic diseases and increasing investments in research and development activities by the market players are anticipated for market growth. The U.S. and Canada are the major emerging countries in North America. There are various market key players in the U.S., such as General Biosystems, Inc., Boster Biological Technology, Creative Biogene, Exonbio, Twist Bioscience, OriGene Technologies, Integrated DNA Technologies, Ansa Biotechnologies, Thermo Fisher Scientific Inc., Genescript, Synbio Technologies, Ginkgo Bioworks, and ProMab. These are the major companies that are expected to drive the growth of the gene synthesis market in North America.

Asia Pacific had the second-largest share of the market in 2023. The increasing number of gene therapies in developing countries and increasing demands from the healthcare sector in this region are expected to drive market growth. India, China, Japan, and South Korea are the major leading companies in the gene synthesis market in the Asia Pacific region.

In China, cutting-edge facilities offer global researchers top-quality plasmid DNA services, cloning, and gene synthesis. China’s worldwide occurrence enables efficient and quick access to their top-most services and helps researchers to focus on their goals with confidence. China is actively supporting its researcher's demand and improving innovation in the field of genetic synthesis sciences.

In India, a fast-expanding Bengaluru-based genomic company, Barcode Bioscience, has succeeded in developing artificial gene synthesis in its no-cost facility and has become the leading Biotech company to initiate end-to-end users at a commercial scale in India. Investments in research and development and infrastructure are expected to enhance the healthcare system in India.

The continuous rise in healthcare spending creates a lucrative opportunity for the growth of the gene synthesis sector. GCC Biotech, Synbio Technologies, Kaneka Eurogentec S.A., Merck KGaA, and Eurofins Scientific are the major key players and are anticipated to drive the growth of the gene synthesis market in the Asia Pacific region.

Market Potential and Growth Opportunity

Expansion of synthetic biology and the rising need for custom-designed constructs

There is an increasing demand for custom-designed synthetic genes and DNA constructs due to the technological advancements in synthetic biology. This involves the development of agricultural improvements, sustainable bio-manufacturing processes, and novel therapeutics. Gene synthesis companies enable them to benefit from this rising need by offering advanced solutions to industries and researchers searching to leverage gene synthetic biology for problem-solving and innovation.

The scalability and flexibility of gene synthesis technologies help market players expand their companies and the landscape of synthetic biology. These are the major opportunities that are expected to enhance the growth of the gene synthesis market in the coming future.

Gene Synthetic Market News

  • In June 2023, a biotechnology company, Eurofins Genomics Blue Heron, launched its in-vitro transcription messenger RNA gene synthesis services. This company specializes in advanced gene synthesis. The company said that the new synthesis services launched to provide an extensive solution for researchers searching for customizable and high-quality mRNA gene synthesis.
  • In May 2023, in Oakland, the world’s leading provider of life-science research, tools, and services company, GenScript Biotech Corporation, launched its breakthrough GenTitan Gene Fragments Synthesis service. This advanced service presented its innovative biopharma tools.

Market Segmentation

By Method

  • Solid-phase synthesis
  • Chip-based synthesis
  • PCR- based Enzyme synthesis

By Service

  • Antibody DNA synthesis
  • Viral DNA synthesis
  • Others

By Application

  • Gene & cell therapy development
  • Vaccine development
  • Diseases diagnosis
  • Others

By End Users

  • Biotechnology & pharmaceutical companies
  • Academic & government research institutes
  • Contract research organizations

Buy this Research Report@

You can place an order or ask any questions, please feel free to contact at | +1 650 460 3308